SNB-19 In Vitro High Content Screening (HCS) Assay

This assay is to provide SNB-19-based In Vitro High Content Screening (HCS) Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

SNB-19

Human

SNB-19 is a human glioblastoma cell line that was isolated from a left parieto-occipital glioblastoma of a 47-year-old male patient in 1980. In a 1988 study, published in Cancer Research Journal, the SNB-19 cell line was the most clonogenic in soft agar and showed the most tumorigenicity in nude mice.

Glioblastoma

Oncology

In Vitro High Content Screening (HCS) Assay

SNB-19-cell based In Vitro High Content Screening (HCS) Assay

HCS is one of the latest techniques used in cancer drug discovery programs. Unlike traditional HTS platforms, HCS provides more visual information about the experiment being conducted. HCS is a very powerful tool for multivariate and quantitative data analysis. Cellbased HCS systems have also gained much attention in biological research and cancer drug discovery programs.

High-throughput Screening, High Content Screening and Reporter Gene Assays